Americans seek compensation for failed Covid-19 treatments from US fund
Skip to main content
  • Home
  • Economy
  • Stocks
  • Analysis
  • World+Biz
  • Sports
  • Features
  • Epaper
  • More
    • Subscribe
    • COVID-19
    • Bangladesh
    • Splash
    • Videos
    • Games
    • Long Read
    • Infograph
    • Interviews
    • Offbeat
    • Thoughts
    • Podcast
    • Quiz
    • Tech
    • Archive
    • Trial By Trivia
    • Magazine
    • Supplement
  • বাংলা
The Business Standard

Thursday
August 11, 2022

Sign In
Subscribe
  • Home
  • Economy
  • Stocks
  • Analysis
  • World+Biz
  • Sports
  • Features
  • Epaper
  • More
    • Subscribe
    • COVID-19
    • Bangladesh
    • Splash
    • Videos
    • Games
    • Long Read
    • Infograph
    • Interviews
    • Offbeat
    • Thoughts
    • Podcast
    • Quiz
    • Tech
    • Archive
    • Trial By Trivia
    • Magazine
    • Supplement
  • বাংলা
THURSDAY, AUGUST 11, 2022
Americans seek compensation for failed Covid-19 treatments from US fund

Coronavirus chronicle

Reuters
11 March, 2021, 05:20 pm
Last modified: 11 March, 2021, 05:30 pm

Related News

  • China calls US 'main instigator' of Ukraine crisis
  • What legal woes does Trump face?
  • Afghan Muslim arrested for killings that shook New Mexico's Islamic community
  • Dhaka got $5.83b as Covid recovery support in 3 years
  • Biden 'concerned' as China extends military drills around Taiwan

Americans seek compensation for failed Covid-19 treatments from US fund

The US government does not publish specifics of claims to the fund, the amount of payouts or why claims are denied

Reuters
11 March, 2021, 05:20 pm
Last modified: 11 March, 2021, 05:30 pm
A woman runs past the Charging Bull sculpture in the Financial District as streets remain less busy due to the continuing outbreak of the coronavirus disease (Covid-19) in the Manhattan borough of New York US, May 5, 2020 at 6:42PM/ Reuters
A woman runs past the Charging Bull sculpture in the Financial District as streets remain less busy due to the continuing outbreak of the coronavirus disease (Covid-19) in the Manhattan borough of New York US, May 5, 2020 at 6:42PM/ Reuters

In March of last year, Steve Cicala took his wife, Susan, to the emergency room at Clara Maass Medical Center in New Jersey to treat a worsening cough and fever, unaware she had Covid-19.

As her breathing and blood pressure deteriorated, she was given azithromycin and hydroxychloroquine and put on a ventilator. Eleven days after being admitted to the same hospital where she had worked for years as a nurse, Susan went into cardiac arrest and died at age 60.

Steve Cicala is now the first person known to be pursuing a Covid-19 claim with a decade-old US government fund that has up to $30 billion that can be used to compensate for serious injuries or deaths caused by treatments or vaccines in the fight against the pandemic.

Covid-19 presents the first serious test of the Countermeasure Injury Compensation Program (CICP) overseen by the Department of Health and Human Services (HHS). The program so far has denied compensation in 90% of the cases filed prior to the pandemic, mostly for H1N1 flu vaccines.

Cicala's claim has not been previously reported.

He could receive around $367,000 from the virtually untapped fund if he can show the treatment caused his wife's death. He is not alleging negligence against the hospital, which is largely protected from liability by an emergency health law.

"There's nothing that's going to bring her back," said Cicala, "but obviously with our two children and now two grandchildren, if there's something that we could do to help them out, that would be nice."

Cicala, 58, said he believed the hospital provided the best care possible. Clara Maass declined to comment.

A DEADLY COMBINATION

The government does not publish specifics of claims to the fund, the amount of payouts or why claims are denied. HHS declined to comment.

A Freedom of Information Act disclosure brought by a law professor and viewed by Reuters shows 48 claims were filed this year and were pending as of Feb. 16, for serious injuries and deaths from vaccines, ventilators and drugs - figures that have not previously been reported.

All of these claims were related to Covid-19.

To encourage life-saving efforts during a declared public health emergency, healthcare providers and drug companies can be shielded from nearly all lawsuits, and claims for serious injuries or deaths are instead filed with the CICP.

That legal protection extends to Covid-19 vaccines by Moderna Inc, Pfizer Inc and partner BioNTech SE, and Johnson & Johnson, as well as approved medicines, which briefly included the antimalaria drug hydroxychloroquine touted by former President Donald Trump.

US regulators revoked the emergency authorization for hydroxychloroquine after studies suggested it was not effective and may pose heart risks for certain patients.

Electrocardiogram records show Susan Cicala's heart rhythms were disrupted by hydroxychloroquine and azithromycin, according to her husband's lawyer, Jonathan Levitt of Frier Levitt.

"Those two in combination are known to be deadly now," said Levitt. "And she was also placed on a ventilator, which as you know, also has some substantial dangers."

Cicala's is one of about a dozen claims Levitt has filed with the fund. He said he has more than 200 clients planning to seek compensation for deaths allegedly caused by failed Covid-19 treatments.

"Our cases are mostly about hydroxychloroquine," said Levitt, who gets paid a portion of successful claims, though he declined to say how much.

US lawsuits over some drugs have run into billions of dollars and protection against liability was seen as key to developing vaccines at breakneck speed during a pandemic.

However, critics said the compensation fund pays out relatively small amounts for serious injuries and lacks transparency.

In its 10-year history, the fund has paid $6 million for 29 claims for vaccine injuries, according to disclosures obtained by Peter Meyers, a Georgetown Law professor and vaccine injury specialist, and viewed by Reuters. Most of those were for the neurological disorder Guillain-Barré syndrome caused by the H1N1 flu vaccine.

The US Centers for Disease Control and Prevention (CDC) estimates about 123 million people received the H1N1 vaccine.

Of the 48 coronavirus-related claims received by the fund, 21 involved Covid-19 vaccines, including three deaths, according to the FOIA information obtained by Meyers.

The CDC said it has received reports of deaths among people who received Covid-19 vaccines, but has no evidence linking the shots to the fatalities.

Based on Meyers' FOIA information, it appears fewer than 25 claims were filed in 2020, and it was not clear whether these were Covid-19 related.

Through the end of January, more than 25 million people in the United States received at least one coronavirus vaccine dose. Meyers said the number of vaccine claims suggests the shots are extremely safe.

Still, he said the program's lack of transparency could undermine support for protecting drug companies from lawsuits and for drugs and vaccines authorized for emergency use.

"It's important to have openness to gain the trust of the American public and to counter the vaccine hesitancy," he said.

Top News / World+Biz

USA / COVID-19

Comments

While most comments will be posted if they are on-topic and not abusive, moderation decisions are subjective. Published comments are readers’ own views and The Business Standard does not endorse any of the readers’ comments.

Top Stories

  • Fuel price hike could have been avoided with BPC savings: CPD
    Fuel price hike could have been avoided with BPC savings: CPD
  • Can’t afford any more losses: BPC chairman
    Can’t afford any more losses: BPC chairman
  • A worker holds a nozzle to pump petrol into a vehicle at a fuel station in Mumbai, India, May 21, 2018. REUTERS/Francis Mascarenhas/File Photo
    Short measure at petrol pumps due to low commissions: Owners' association

MOST VIEWED

  • Workers wearing protective suits arrive to a building under lockdown for compulsory testing, following the coronavirus disease (COVID-19) outbreak in Hong Kong, China January 7, 2022. Photo :Reuters
    Hong Kong cuts Covid quarantine stay for incoming travellers
  • People line up for nucleic acid tests during lockdown, amid the coronavirus disease (COVID-19) pandemic, in Shanghai, China, May 26, 2022. REUTERS/Aly Song
    China's Sanya holiday hotspot shuts duty-free malls, venues to curb Covid
  • FILE PHOTO: People wearing protective face masks walk amid concerns over the new coronavirus disease (COVID-19) in Pyongyang, North Korea May 15, 2020, in this photo released by Kyodo. Mandatory credit Kyodo/via REUTERS
    North Korea marks end of first Covid wave, but risks persist
  • A woman holds a small bottle labelled with a "Coronavirus COVID-19 Vaccine" sticker and a medical syringe in this illustration taken October 30, 2020. REUTERS/Dado Ruvic/File Photo
    South Africa reports first death causally linked to Covid vaccine
  • 'Living with Covid': Where the pandemic could go next
    'Living with Covid': Where the pandemic could go next
  • A worker, wearing a protective suit following the coronavirus disease (COVID-19) outbreak, transports luggage on the tarmac of Wuhan Tianhe International Airport, on a hot summer day in Wuhan, Hubei province, China July 14, 2022. cnsphoto via REUTERS
    China's Wuhan locks down 1m residents amid new Covid cases

Related News

  • China calls US 'main instigator' of Ukraine crisis
  • What legal woes does Trump face?
  • Afghan Muslim arrested for killings that shook New Mexico's Islamic community
  • Dhaka got $5.83b as Covid recovery support in 3 years
  • Biden 'concerned' as China extends military drills around Taiwan

Features

The elevated ground is made out of soil on which grass and trees have grown. This grass-covered elevated ground extends to the perimeter of the establishment. Photo: Maruf Raihan

Aman Mosque: Where form and function complement each other

1d | Habitat
Photo: BSS

Begum Fazilatunnessa Mujib . . . woman of moral power

2d | Thoughts
Will Glass Cosmetics be your next skincare holy grail?

Will Glass Cosmetics be your next skincare holy grail?

2d | Brands
Akij Tableware: More than just dishes on a table

Akij Tableware: More than just dishes on a table

2d | Brands

More Videos from TBS

Salimullah Khan on Ahmad Safa's thinking on nature

Salimullah Khan on Ahmad Safa's thinking on nature

1h | Videos
Will Tata turn around the Indian car market?

Will Tata turn around the Indian car market?

1h | Videos
Those who remain in morgue for years after death

Those who remain in morgue for years after death

4h | Videos
Is Donald Trump getting caught in tax evasion case?

Is Donald Trump getting caught in tax evasion case?

4h | Videos

Most Read

1
Dollar crisis: BB orders removal of 6 banks’ treasury chiefs 
Banking

Dollar crisis: BB orders removal of 6 banks’ treasury chiefs 

2
Diesel price hiked by Tk34 per litre, Octane by Tk46
Energy

Diesel price hiked by Tk34 per litre, Octane by Tk46

3
Housing projects sprouting up by Dhaka-Mawa expressway
Real Estate

Housing projects sprouting up by Dhaka-Mawa expressway

4
Infographic: TBS
Banking

Dollar rate will be left to market after two months: Governor

5
Photo: Collected
Transport

Will Tokyo’s traffic model solve Dhaka’s gridlocks?

6
Bangladesh to resume talks for Ukrainian wheat import
Economy

Bangladesh to resume talks for Ukrainian wheat import

EMAIL US
[email protected]
FOLLOW US
WHATSAPP
+880 1847416158
The Business Standard
  • About Us
  • Contact us
  • Sitemap
  • Privacy Policy
  • Comment Policy
Copyright © 2022
The Business Standard All rights reserved
Technical Partner: RSI Lab

Contact Us

The Business Standard

Main Office -4/A, Eskaton Garden, Dhaka- 1000

Phone: +8801847 416158 - 59

Send Opinion articles to - [email protected]

For advertisement- [email protected]